Comunicación corta
Tratamiento con ciclosporina al 0,1% (Ikervis®) en conjuntivitis corticodependiente asociada a dupilumab
Cyclosporine 0.1% (Ikervis®) treatment in steroid-dependent dupilumab-associated conjunctivitis
Leído
75
Vecesse ha leído el artículo
24
Total PDF
51
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 9 | 1 | 0 | 1 |
| 2024 7 | 2 | 0 | 2 |
| 2023 3 | 2 | 6 | 8 |
| 2022 11 | 1 | 0 | 1 |
| 2021 8 | 1 | 0 | 1 |
| 2021 5 | 1 | 0 | 1 |
| 2021 3 | 1 | 0 | 1 |
| 2020 1 | 3 | 0 | 3 |
| 2020 6 | 2 | 2 | 4 |
| 2020 4 | 1 | 0 | 1 |
| 2020 3 | 1 | 4 | 5 |
| 2020 2 | 2 | 2 | 4 |
| 2019 10 | 2 | 0 | 2 |
| 2019 9 | 7 | 0 | 7 |
| 2019 8 | 24 | 8 | 32 |
| 2019 6 | 0 | 2 | 2 |
Mostrar todo
